FindTrial
Sign In

Prospective observational study on the effects of sedative drugs in palliative sedation

Prospective observational study on the effects of sedative drugs in palliative sedation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057790
Enrollment
Unknown
Registered
2022-03-17
Start date
2022-03-20
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage disease

Interventions

case series:None

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. End-stage patients; 2. Have accepted systemic palliative care; 3. The presence of one or more intractable symptoms and unbearable pain; 4. There is a subjective willingness to accept palliative sedation (the patient himself or his agent applies).

Exclusion criteria

Exclusion criteria: 1. There are reversible factors causing painful symptoms that have not been corrected; 2. Refusing to sign the study informed consent.

Design outcomes

Primary

MeasureTime frame
The success rate of palliative sedation in achieving the target efficacy;—

Secondary

MeasureTime frame
Richmond Agitation-Sedation Scale;Communication Capacity Scale;Palliative sedation incidence of adverse reactions;Patient/family satisfaction;—

Countries

China

Contacts

Public ContactLiu Hongju

Peking Union Medical College Hospital (CAMS)

kikukoliu@126.com+86 13683211151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026